As the world's leading e-liquid technology company, Zinwi Biotech focuses on R&D and innovation, opens a new game in the process of change and works on the journey of globalization.
On the road of pursuing quality, Zinwi cannot do without years of persistence and innovation, and it is also inseparable from the strong support of CNAS-accredited laboratories. The CNAS-accredited laboratory is like a hard armor, which has built a solid safety fortress for the e-liquid products of Zinwi.
What is CNAS certification?
China National Accreditation Service for Conformity Assessment (English abbreviation: CNAS), is the only national accreditation body for conformity assessment established and authorized by the National Certification and Accreditation Administration Committee in accordance with the provisions of the "Regulations on Certification and Accreditation of the People's Republic of China". The accreditation work of relevant institutions such as institutions, laboratories and inspection agencies. The accreditation audit takes a long time and is difficult to pass. It is an authoritative accreditation body for international mutual recognition.
CNAS for conformity assessment has been integrated into the international accreditation and mutual recognition system, and plays a pivotal role. At present, China has signed mutual recognition agreements with more than 140 other countries and regions.
The “quality code” of Zinwi Biotech
As the first company in the e-liquid industry to obtain the CNAS accreditation laboratory qualification (it was obtained the certificate for the first time in April 2021, and the CNAS official website of the China National Accreditation Service for Conformity Assessment can be checked), Zinwi Biotech starts from "people, machine, material, method, environment and testing”, the six dimensions, to improve the testing standards in an all-round and multi-dimensional way, and realize the upgrading of the laboratory system.
At present, Zinwi Biotech has 47 CNAS accreditation capabilities, and is gradually expanding to more than 100 accreditation capabilities. The laboratory is equipped with world-renowned brands of high-performance liquid chromatography (HPLC), gas chromatography (GC), gas chromatography-mass spectrometry (GC-MS), triple quadrupole liquid-mass spectrometry (LC-MS- MS), Inductively Coupled Plasma Mass Spectrometer (ICP-MS), (LC-MS) LC-MS, High Resolution Gas Chromatography (GC-OB) and other precision instruments.
The capabilities authorized by CNAS cover the various processes of research and development and production of e-liquids, through the quantitative detection of physical and chemical indicators and heavy metals, the screening of prohibited and restricted substances (such as benzene series, 82 kinds of additives in "Electronic Cigarettes" GB41700-2022 substances, aldehydes, ketones, sweeteners, pulegone, and nicotine), combined with quantitative and qualitative analysis, to realize the quality monitoring of raw materials and e-liquid, and to ensure the quality and safety of the e-liquid in an all-round way.
At present, the CNAS accredited laboratory of Zinwi Biotech not only has the technical ability to carry out testing work according to the corresponding accreditation criteria, but its laboratory ability has also been recognized by other members of the ilac-MRA organization. At the same time, through standardized operation, the laboratory introduces the testing standards of international authoritative organizations and various countries to further improve the accuracy, effectiveness and scientificity of testing, laying a good foundation for the production of high-quality and safe e-liquid.
CNAS-accredited laboratory of Zinwi Biotech assists the rapid development of customer
Relying on a sound supervision mechanism and a standardized testing process, the testing data of CNAS-accredited laboratories are extremely authoritative and reliable. In addition, the detection equipment of Zinwi Biotech has an efficient detection capability that meets the standard performance of the e-liquid. It can quickly issue accurate test results, ensuring that the CNAS test reports and SDS safety technical specifications issued by Zinwi Biotech are standard, scientific and complete, reducing costs and increasing efficiency for customers.
At the same time, Zinwi Biotech provides timely feedback on market information, adapts to global regulatory trends, and helps CNAS-accredited laboratories to achieve systematic upgrades. From testing services to providing TPD, PMTA, REACH and other certification and registration support for customer products, empowering brands to enter the international stage.
Improving quality capabilities and helping globalization
At present, based on the CNAS accreditation standard (ISO/IEC 17025), Zinwi Biotech has established a complete laboratory and a scientific quality inspection process. The perfect quality assurance system has achieved full coverage of the production process and implemented safety into every detail of the product.
At the same time, Zinwi Biotech has built a professional quality control and testing team and a scientific experimental platform, which has realized the whole process control and comprehensive quality management from raw material procurement, production and processing, product manufacturing, finished product testing, product warehousing and after-sales quality.
CNAS-accredited laboratories is an important part of quality assurance. The testing team of Zinwi Biotech participates in proficiency testing activities organized by CNAS-accredited proficiency testing providers (PTPs) more than three times a year and has achieved satisfactory results. Adhering to the original intention of quality, continuous improvement and upgrading. Relying on CNAS, Zinwi Biotech will also take advantage of the momentum, and on the road to globalization, it will always practice the company mission of " Driven by Innovation, Exploring the future" to create higher-quality e-liquid.